Cargando…

The efficacy of DNA mismatch repair enzyme immunohistochemistry as a screening test for hypermutated gliomas

A subset of gliomas has DNA repair defects that lead to hypermutated genomes. While such tumors are resistant to alkylating chemotherapies, they may also express more mutant neoantigens on their cell surfaces, and thus be more responsive to immunotherapies. A fast, inexpensive method of screening fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCord, Matthew, Steffens, Alicia, Javier, Rodrigo, Kam, Kwok-Ling, McCortney, Kathleen, Horbinski, Craig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017562/ https://www.ncbi.nlm.nih.gov/pubmed/32051040 http://dx.doi.org/10.1186/s40478-020-0892-2

Ejemplares similares

The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma
por: Javier, Rodrigo, et al.
Publicado: (2022)

Longitudinal Study of Boxing Therapy in Parkinson’s Disease, Including Adverse Impacts of the COVID-19 Lockdown
por: Horbinski, Craig, et al.
Publicado: (2021)

Longitudinal observational study of boxing therapy in Parkinson’s disease, including adverse impacts of the COVID-19 lockdown
por: Horbinski, Craig, et al.
Publicado: (2021)

Discovery of novel glioma serum biomarkers by proximity extension assay
por: Ghorbani, Atefeh, et al.
Publicado: (2023)

Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results
por: McCord, Matthew, et al.
Publicado: (2023)

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts
por: McCord, Matthew, et al.
Publicado: (2022)

DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers
por: Mas-Ponte, David, et al.
Publicado: (2020)

Impact of formalin fixation on mismatch repair protein evaluation by immunohistochemistry
por: Grillo, Federica, et al.
Publicado: (2023)

Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency
por: Lindsay, Holly, et al.
Publicado: (2019)

Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma
por: Cheng, Xing, et al.
Publicado: (2023)

Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma
por: Cheng, Xing, et al.
Publicado: (2023)

Mechanisms and therapeutic implications of hypermutation in gliomas
por: Touat, Mehdi, et al.
Publicado: (2020)

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors
por: Drumm, Michael R., et al.
Publicado: (2023)

Repertoire Sequencing of B Cells Elucidates the Role of UNG and Mismatch Repair Proteins in Somatic Hypermutation in Humans
por: IJspeert, Hanna, et al.
Publicado: (2019)

LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma
por: Baisiwala, Shivani, et al.
Publicado: (2020)

IMMU-10. PILOCYTIC ASTROCYTOMAS SHOW EVIDENCE OF INTRINSIC IMMUNE SURVEILLANCE AND ACTIVATION WITHIN THE TUMOR MICROENVIRONMENT
por: Najem, Hinda, et al.
Publicado: (2023)

Concordance between microsatellite instability testing and immunohistochemistry for mismatch repair proteins and efficient screening of mismatch repair deficient gastric cancer
por: Yamamoto, Gou, et al.
Publicado: (2023)

Lynch syndrome–associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome
por: Yang, Chen, et al.
Publicado: (2019)

Genes and Proteomes Associated With Increased Mutation Frequency and Multidrug Resistance of Naturally Occurring Mismatch Repair-Deficient Salmonella Hypermutators
por: Sheng, Huanjing, et al.
Publicado: (2020)

Audit of routine immunohistochemistry testing for mismatch repair proteins at diagnosis of colorectal cancer under the age of 50
por: Lipton, L, et al.
Publicado: (2012)

Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
por: Jung, Jiyoon, et al.
Publicado: (2017)

The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
por: Favier, Amelia, et al.
Publicado: (2022)

Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry
por: Noei Teymoordash, Somayyeh, et al.
Publicado: (2022)

Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient
por: McCord, Matthew, et al.
Publicado: (2021)

SerpinB3 drives cancer stem cell survival in glioblastoma
por: Lauko, Adam, et al.
Publicado: (2022)

Different Mismatch Repair Deficiencies All Have the Same Effects on Somatic Hypermutation: Intact Primary Mechanism Accompanied by Secondary Modifications
por: Kim, Nayun, et al.
Publicado: (1999)

Increased Hypermutation at G and C Nucleotides in Immunoglobulin Variable Genes from Mice Deficient in the MSH2 Mismatch Repair Protein
por: Phung, Quy H., et al.
Publicado: (1998)

Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan
por: Sugano, Kokichi, et al.
Publicado: (2016)

Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
por: Daniel, Paul, et al.
Publicado: (2019)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Aslan, Katrin, et al.
Publicado: (2020)

Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
por: Noll, Alyssa, et al.
Publicado: (2023)

Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review
por: Budhiraja, Shreya, et al.
Publicado: (2023)

LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression
por: Khan, Fatima, et al.
Publicado: (2023)

BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer
por: Toon, Christopher W, et al.
Publicado: (2014)

Sebaceous “adenoma” of an arm recurring as a carcinoma: The value of DNA mismatch repair gene expression immunohistochemistry
por: Saal, Ryan C., et al.
Publicado: (2022)

The Role of DNA Repair in Somatic Hypermutation of Immunoglobulin Genes
por: Kim, Nayun, et al.
Publicado: (1998)

Utilizing microsatellite instability and immunohistochemistry to clinically interpret a novel germline mismatch repair mutation of uncertain significance
por: Ducaine, Whitney L, et al.
Publicado: (2011)

Mismatch Repair Protein Expression in Endometrial Cancer: Assessing Concordance and Unveiling Pitfalls in Two Different Immunohistochemistry Assays
por: Yoshida, Hiroshi, et al.
Publicado: (2023)

Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas
por: Koneru, Tejaswi, et al.
Publicado: (2021)

HGG-32. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS
por: Boynton, Adam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tpg6tlsgan75u0i9k4d2hlepem